1. Home
  2. GBIO vs SPRU Comparison

GBIO vs SPRU Comparison

Compare GBIO & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • SPRU
  • Stock Information
  • Founded
  • GBIO 2016
  • SPRU 2008
  • Country
  • GBIO United States
  • SPRU United States
  • Employees
  • GBIO N/A
  • SPRU N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • SPRU Auto Parts:O.E.M.
  • Sector
  • GBIO Health Care
  • SPRU Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • SPRU Nasdaq
  • Market Cap
  • GBIO 29.2M
  • SPRU 34.9M
  • IPO Year
  • GBIO 2020
  • SPRU N/A
  • Fundamental
  • Price
  • GBIO $0.38
  • SPRU $1.99
  • Analyst Decision
  • GBIO Strong Buy
  • SPRU
  • Analyst Count
  • GBIO 4
  • SPRU 0
  • Target Price
  • GBIO $7.33
  • SPRU N/A
  • AVG Volume (30 Days)
  • GBIO 558.2K
  • SPRU 46.5K
  • Earning Date
  • GBIO 08-06-2025
  • SPRU 08-13-2025
  • Dividend Yield
  • GBIO N/A
  • SPRU N/A
  • EPS Growth
  • GBIO N/A
  • SPRU N/A
  • EPS
  • GBIO N/A
  • SPRU N/A
  • Revenue
  • GBIO $24,556,000.00
  • SPRU $87,638,000.00
  • Revenue This Year
  • GBIO N/A
  • SPRU $2.12
  • Revenue Next Year
  • GBIO N/A
  • SPRU N/A
  • P/E Ratio
  • GBIO N/A
  • SPRU N/A
  • Revenue Growth
  • GBIO 146.47
  • SPRU 9.48
  • 52 Week Low
  • GBIO $0.32
  • SPRU $1.42
  • 52 Week High
  • GBIO $3.65
  • SPRU $3.68
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 48.07
  • SPRU 55.21
  • Support Level
  • GBIO $0.35
  • SPRU $1.82
  • Resistance Level
  • GBIO $0.41
  • SPRU $1.99
  • Average True Range (ATR)
  • GBIO 0.03
  • SPRU 0.11
  • MACD
  • GBIO -0.00
  • SPRU 0.01
  • Stochastic Oscillator
  • GBIO 30.11
  • SPRU 54.55

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

Share on Social Networks: